Draft:InBody

South Korean medical device company From Wikipedia, the free encyclopedia

InBody Co., Ltd. is a South Korean medical device manufacturer that develops body composition analysis devices based on bioelectrical impedance analysis (BIA). Founded in 1996 and headquartered in Seoul, South Korea, the company produces body composition analyzers used in healthcare, research, sports science, and fitness industries.

Native name
인바디
Company typePublic
IndustryMedical devices
Founded1996
Quick facts Native name, Company type ...
InBody Co., Ltd.
Native name
인바디
Company typePublic
IndustryMedical devices
Founded1996
FounderKi-Chul Cha
HeadquartersSeoul, South Korea
Key people
Ki-Chul Cha (Founder and CEO)
ProductsBody composition analyzers, body water analyzers, blood pressure monitors
Websitewww.inbody.com
Close

InBody devices measure body composition indicators including skeletal muscle mass, body fat mass, and total body water distribution. The company's technology is based on segmental bioelectrical impedance analysis, which measures impedance across different parts of the body.[1]

History

InBody was founded in 1996 by biomedical engineer Ki-Chul Cha. The company was initially established under the name Biospace Co., Ltd. and later changed its corporate name to InBody.[2]

The company developed body composition analyzers based on segmental multi-frequency bioelectrical impedance analysis technology. The approach analyzes electrical impedance separately in different body segments to estimate body composition parameters such as fat mass, lean body mass, and body water distribution.

During the 2000s and 2010s, InBody expanded internationally by establishing subsidiaries and distribution networks in North America, Europe, and Asia. Its body composition analyzers became widely used in hospitals, research institutions, sports science laboratories, and fitness centers.[3]

In 2023, the company signed a contract to supply body composition analyzers to the United States Marine Corps.[4]

In October 2025, Naver announced a strategic partnership with InBody as part of its expansion into digital healthcare services. Naver acquired an 8.5 percent stake in the company as part of the collaboration.[5]

Technology

InBody devices use bioelectrical impedance analysis (BIA), a technique that estimates body composition by measuring electrical resistance through body tissues.

The company's analyzers measure impedance separately across multiple body segments, including the arms, legs, and trunk. This method allows estimation of body composition indicators such as fat mass, lean body mass, skeletal muscle mass, and total body water.

Body composition analysis devices are used in medical research, clinical nutrition, obesity management, and sports science.

Products

The company's product portfolio includes:

  • Body composition analyzers used in medical and fitness settings
  • Body water analyzers designed for clinical assessment of body fluid distribution
  • Automatic blood pressure monitors
  • Consumer health monitoring devices

Global operations

InBody distributes its products globally through subsidiaries and regional distribution partners. The company's body composition analyzers are used in a variety of settings including hospitals, research institutions, sports organizations, and fitness centers worldwide.

Reports in international media have described the company's international expansion as part of broader growth in digital health and body composition monitoring technologies.[6]

See also

  • Bioelectrical impedance analysis
  • Body composition

References

Related Articles

Wikiwand AI